The human NK cell response to yellow fever virus 17D is primarily governed by NK cell differentiation independently of NK cell education

Journal of Immunology

Volumn 195, Issue 7, 2015, Pages 3262-3272

  Marquardt, Nicole ^a   Ivarsson, Martin A ^a   Blom, Kim ^a   Gonzalez, Veronica D ^a   Braun, Monika ^a   Falconer, Karolin ^a   Gustafsson, Rasmus ^b   Fogdell Hahn, Anna ^b   Sandberg, Johan K ^a   Michaëlsson, Jakob ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CD69 ANTIGEN; HLA ANTIGEN CLASS 1; INTERFERON; INTERLEUKIN 12; INTERLEUKIN 15; INTERLEUKIN 18; KI 67 ANTIGEN; YELLOW FEVER VACCINE; CD57 ANTIGEN; IL12A PROTEIN, HUMAN; INTERLEUKIN 12P35; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR; LECTIN; LEUKOCYTE ANTIGEN; LIVE VACCINE; NEUTRALIZING ANTIBODY; T LYMPHOCYTE ANTIGEN; VIRUS VACCINE;

ADULT; ANTIGEN EXPRESSION; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; FLAVIVIRUS INFECTION; FLOW CYTOMETRY; GENOTYPE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; K562 CELL LINE; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE FUNCTION; LYMPHOCYTE PROLIFERATION; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; SINGLE DRUG DOSE; VIRUS LOAD; YELLOW FEVER VIRUS; YELLOW FEVER VIRUS INFECTION; B LYMPHOCYTE; BIOSYNTHESIS; BLOOD; CELL DIFFERENTIATION; CELL PROLIFERATION; CYTOLOGY; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM; MIDDLE AGED; T LYMPHOCYTE;

ADULT; ANTIBODIES, NEUTRALIZING; ANTIGENS, CD; ANTIGENS, CD57; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; B-LYMPHOCYTES; CELL DIFFERENTIATION; CELL PROLIFERATION; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; INTERFERON TYPE I; INTERLEUKIN-12 SUBUNIT P35; INTERLEUKIN-18; K562 CELLS; KI-67 ANTIGEN; KILLER CELLS, NATURAL; LECTINS, C-TYPE; LYMPHOCYTE ACTIVATION; MIDDLE AGED; RECEPTORS, KIR; T-LYMPHOCYTES; VACCINES, ATTENUATED; VIRAL LOAD; VIRAL VACCINES; YELLOW FEVER VACCINE; YELLOW FEVER VIRUS;

EID: 84942475226     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1401811     Document Type: Article

References (37)

1. Lodoen, M. B., and L. L. Lanier. 2006. Natural killer cells as an initial defense against pathogens. Curr. Opin. Immunol. 18: 391-398.
2. Biron, C. A., K. S. Byron, and J. L. Sullivan. 1989. Severe herpesvirus infections in an adolescent without natural killer cells. N. Engl. J. Med. 320: 1731-1735.
3. Foley, B., S. Cooley, M. R. Verneris, M. Pitt, J. Curtsinger, X. Luo, S. Lopez-Vergès, L. L. Lanier, D. Weisdorf, and J. S. Miller. 2012. Cytomegalovirus reactivation after allogeneic transplantation promotes a lasting increase in educated NKG2C+ natural killer cells with potent function. Blood 119: 2665-2674.
4. Lopez-Vergès, S., J. M. Milush, B. S. Schwartz, M. J. Pando, J. Jarjoura, V. A. York, J. P. Houchins, S. Miller, S.-M. Kang, P. J. Norris, et al. 2011. Expansion of a unique CD57+NKG2Chi natural killer cell subset during acute human cytomegalovirus infection. Proc. Natl. Acad. Sci. USA 108: 14725-14732.
5. Björkström, N. K., T. Lindgren, M. Stoltz, C. Fauriat, M. Braun, M. Evander, J. Michaëlsson, K.-J. Malmberg, J. Klingström, C. Ahlm, and H.-G. Ljunggren. 2011. Rapid expansion and long-term persistence of elevated NK cell numbers in humans infected with hantavirus. J. Exp. Med. 208: 13-21.
6. Petitdemange, C., P. Becquart, N. Wauquier, V. Béziat, P. Debré, E. M. Leroy, and V. Vieillard. 2011. Unconventional repertoire profile is imprinted during acute chikungunya infection for natural killer cells polarization toward cytotoxicity. PLoS Pathog. 7: e1002268.
7. Balfour, H. H., Jr., O. A. Odumade, D. O. Schmeling, B. D. Mullan, J. A. Ed, J. A. Knight, H. E. Vezina, W. Thomas, and K. A. Hogquist. 2013. Behavioral, virologic, and immunologic factors associated with acquisition and severity of primary Epstein-Barr virus infection in university students. J. Infect. Dis. 207: 80-88.
8. Alter, G., N. Teigen, B. T. Davis, M. M. Addo, T. J. Suscovich, M. T. Waring, H. Streeck, M. N. Johnston, K. D. Staller, M. T. Zaman, et al. 2005. Sequential deregulation of NK cell subset distribution and function starting in acute HIV-1 infection. Blood 106: 3366-3369.
9. Lanier, L. L. 2008. Up on the tightrope: natural killer cell activation and inhibition. Nat. Immunol. 9: 495-502.
10. Moretta, A., M. Vitale, C. Bottino, A. M. Orengo, L. Morelli, R. Augugliaro, M. Barbaresi, E. Ciccone, and L. Moretta. 1993. P58 molecules as putative receptors for major histocompatibility complex (MHC) class I molecules in human natural killer (NK) cells. Anti-p58 antibodies reconstitute lysis of MHC class I-protected cells in NK clones displaying different specificities. J. Exp. Med. 178: 597-604.
11. Houchins, J. P., L. L. Lanier, E. C. Niemi, J. H. Phillips, and J. C. Ryan. 1997. Natural killer cell cytolytic activity is inhibited by NKG2-A and activated by NKG2-C. J. Immunol. 158: 3603-3609.
12. Anfossi, N., P. André, S. Guia, C. S. Falk, S. Roetynck, C. A. Stewart, V. Breso, C. Frassati, D. Reviron, D. Middleton, et al. 2006. Human NK cell education by inhibitory receptors for MHC class I. Immunity 25: 331-342.
13. Kim, S., J. Poursine-Laurent, S. M. Truscott, L. Lybarger, Y. J. Song, L. Yang, A. R. French, J. B. Sunwoo, S. Lemieux, T. H. Hansen, and W. M. Yokoyama. 2005. Licensing of natural killer cells by host major histocompatibility complex class I molecules. Nature 436: 709-713.
14. Juelke, K., M. Killig, M. Luetke-Eversloh, E. Parente, J. Gruen, B. Morandi, G. Ferlazzo, A. Thiel, I. Schmitt-Knosalla, and C. Romagnani. 2010. CD62L expression identifies a unique subset of polyfunctional CD56dim NK cells. Blood 116: 1299-1307.
15. Björkström, N. K., P. Riese, F. Heuts, S. Andersson, C. Fauriat, M. A. Ivarsson, A. T. Björklund, M. Flodström-Tullberg, J. Michaëlsson, M. E. Rottenberg, et al. 2010. Expression patterns of NKG2A, KIR, and CD57 define a process of CD56dim NK-cell differentiation uncoupled from NK-cell education. Blood 116: 3853-3864.
16. Béziat, V., L. L. Liu, J.-A. Malmberg, M. A. Ivarsson, E. Sohlberg, A. T. Björklund, C. Retière, E. Sverremark-Ekström, J. Traherne, P. Ljungman, et al. 2013. NK cell responses to cytomegalovirus infection lead to stable imprints in the human KIR repertoire and involve activating KIRs. Blood 121: 2678-2688.
17. Lopez-Vergès, S., J. M. Milush, S. Pandey, V. A. York, J. Arakawa-Hoyt, H. Pircher, P. J. Norris, D. F. Nixon, and L. L. Lanier. 2010. CD57 defines a functionally distinct population of mature NK cells in the human CD56dimCD16+ NK-cell subset. Blood 116: 3865-3874.
18. Blom, K., M. Braun, M. A. Ivarsson, V. D. Gonzalez, K. Falconer, M. Moll, H.-G. Ljunggren, J. Michaëlsson, and J. K. Sandberg. 2013. Temporal dynamics of the primary human T cell response to yellow fever virus 17D as it matures from an effector- to a memory-type response. J. Immunol. 190: 2150-2158.
19. Gaucher, D., R. Therrien, N. Kettaf, B. R. Angermann, G. Boucher, A. Filali-Mouhim, J. M. Moser, R. S. Mehta, D. R. Drake, III, E. Castro, et al. 2008. Yellow fever vaccine induces integrated multilineage and polyfunctional immune responses. J. Exp. Med. 205: 3119-3131.
20. Kohler, S., N. Bethke, M. Böthe, S. Sommerick, M. Frentsch, C. Romagnani, M. Niedrig, and A. Thiel. 2012. The early cellular signatures of protective immunity induced by live viral vaccination. Eur. J. Immunol. 42: 2363-2373.
21. Miller, J. D., R. G. van der Most, R. S. Akondy, J. T. Glidewell, S. Albott, D. Masopust, K. Murali-Krishna, P. L. Mahar, S. Edupuganti, S. Lalor, et al. 2008. Human effector and memory CD8+ T cell responses to smallpox and yellow fever vaccines. Immunity 28: 710-722.
22. Querec, T. D., R. S. Akondy, E. K. Lee, W. Cao, H. I. Nakaya, D. Teuwen, A. Pirani, K. Gernert, J. Deng, B. Marzolf, et al. 2009. Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans. Nat. Immunol. 10: 116-125.
23. Martins, M. A., M. L. Silva, S. M. Elói-Santos, J. G. Ribeiro, V. Peruhype-Magalhães, A. P. Marciano, A. Homma, E. G. Kroon, A. Teixeira-Carvalho, and O. A. Martins-Filho. 2008. Innate immunity phenotypic features point toward simultaneous raise of activation and modulation events following 17DD live attenuated yellow fever first-time vaccination. Vaccine 26: 1173-1184.
24. Neves, P. C., D. C. Matos, R. Marcovistz, and R. Galler. 2009. TLR expression and NK cell activation after human yellow fever vaccination. Vaccine 27: 5543-5549.
25. Silva, M. L., M. A. Martins, L. R. Espírito-Santo, A. C. Campi-Azevedo, D. Silveira-Lemos, J. G. Ribeiro, A. Homma, E. G. Kroon, A. Teixeira-Carvalho, S. M. Elói-Santos, and O. A. Martins-Filho. 2011. Characterization of main cytokine sources from the innate and adaptive immune responses following primary 17DD yellow fever vaccination in adults. Vaccine 29: 583-592.
26. Muyanja, E., A. Ssemaganda, P. Ngauv, R. Cubas, H. Perrin, D. Srinivasan, G. Canderan, B. Lawson, J. Kopycinski, A. S. Graham, et al. 2014. Immune activation alters cellular and humoral responses to yellow fever 17D vaccine. J. Clin. Invest. 124: 3147-3158.
27. Heinz, F. X., and K. Stiasny. 2012. Flaviviruses and flavivirus vaccines. Vaccine 30: 4301-4306.
28. Gustafsson, R. K., E. E. Engdahl, O. Hammarfjord, S. B. Adikari, M. Lourda, J. Klingström, M. Svensson, and A. Fogdell-Hahn. 2013. Human herpesvirus 6A partially suppresses functional properties of DC without viral replication. PLoS One 8: e58122.
29. Chijioke, O., A. Müller, R. Feederle, M. H. Barros, C. Krieg, V. Emmel, E. Marcenaro, C. S. Leung, O. Antsiferova, V. Landtwing, et al. 2013. Human natural killer cells prevent infectious mononucleosis features by targeting lytic Epstein-Barr virus infection. Cell Reports 5: 1489-1498.
30. Orr, M. T.,W. J. Murphy, and L. L. Lanier. 2010. 'Unlicensed' natural killer cells dominate the response to cytomegalovirus infection. Nat. Immunol. 11: 321-327.
31. Momburg, F., A. Müllbacher, and M. Lobigs. 2001. Modulation of transporter associated with antigen processing (TAP)-mediated peptide import into the endoplasmic reticulum by flavivirus infection. J. Virol. 75: 5663-5671.
32. Müllbacher, A., and M. Lobigs. 1995. Up-regulation of MHC class I by flavivirusinduced peptide translocation into the endoplasmic reticulum. Immunity 3: 207-214.
33. Lobigs, M., R. V. Blanden, and A. Müllbacher. 1996. Flavivirus-induced upregulation of MHC class I antigens; implications for the induction of CD8+ T-cell-mediated autoimmunity. Immunol. Rev. 152: 5-19.
34. Waggoner, S. N., M. Cornberg, L. K. Selin, and R. M. Welsh. 2012. Natural killer cells act as rheostats modulating antiviral T cells. Nature 481: 394-398.
35. Sun, J. C., S. Madera, N. A. Bezman, J. N. Beilke, M. H. Kaplan, and L. L. Lanier. 2012. Proinflammatory cytokine signaling required for the generation of natural killer cell memory. J. Exp. Med. 209: 947-954.
36. Paust, S., H. S. Gill, B.-Z. Wang, M. P. Flynn, E. A. Moseman, B. Senman, M. Szczepanik, A. Telenti, P. W. Askenase, R. W. Compans, and U. H. von Andrian. 2010. Critical role for the chemokine receptor CXCR6 in NK cell-mediated antigen-specific memory of haptens and viruses. Nat. Immunol. 11: 1127-1135.
37. Romee, R., S. E. Schneider, J. W. Leong, J. M. Chase, C. R. Keppel, R. P. Sullivan, M. A. Cooper, and T. A. Fehniger. 2012. Cytokine activation induces human memory-like NK cells. Blood 120: 4751-4760.